Radiopharma Roundtable Series | The Bracken Group

Radiopharma Roundtable Series

Expert peer conversations on the future of radiopharmaceutical development — trial complexity, site readiness, patient identification, and the path to market, discussed by the people doing the work.

Register for the next session →
Watch past sessions ↓ Grab recaps ↓
Next session

The panel changes. The candid format doesn't.

Register for Session 3 →
On demand

Watch past sessions

Session 2 · Recorded September 16, 2026

Short Half-Life, Long To-Do List: Solving Early Radiopharma Development Challenges

Ben Larimer, PhD · Anna Pokorska-Bocci, PhD · Deepak Behera, MD · Colin Miller, PhD, FIPEM, CSCI

Click the video above to watch the full session on demand.

Just want the highlights? Get the session recap →
Session 1 · Recorded June 11, 2026

When Trials Get Too Complex: Does Radiopharmaceutical Development Have a Short Half-Life?

Ben Larimer, PhD · Colin Miller, PhD, FIPEM, CSCI · Sandy McEwan, MB, MSc, FRCPC · Ovid Trifan, MD, PhD

Click the video above to watch the full session on demand.

Just want the highlights? Get the session recap →

These conversations come out of the work we do every day.

Bracken's consultants support radiopharmaceutical programs across strategy, clinical operations, imaging, and regulatory. If your program is navigating similar questions, we're glad to talk.

Explore radiopharmaceutical consulting → Meet our consultants →
Questions
What is the Bracken Radiopharma Roundtable? +

It's an ongoing conversation series that brings experienced peers together around the strategic, operational, clinical, and commercial questions shaping radiopharmaceutical development today — from trial complexity and site readiness to patient identification and market evolution. The format is candid and peer-to-peer: the people actually doing this work, comparing notes in the open.

How do I attend an upcoming session? +

Register through the pre-registration form. We'll send you the session details and joining information ahead of each roundtable.

Can I suggest a topic or question? +

Absolutely — and we hope you will. When you register, you can submit the questions and topics you most want explored. Each session's agenda is shaped in part by what attendees bring to it.

Where can I watch past sessions? +

Recordings are available on demand on this page. Session 1, "When Trials Get Too Complex," is available now, with future sessions added here after they air.

Who takes part in the roundtables? +

Experienced peers from across the radiopharmaceutical field — bringing clinical, operational, regulatory, and commercial perspectives. It's built by peers, for peers: a candid, practical discussion grounded in real programs rather than a podium.